Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...
Supported by positive data from Phase 2b FASCINATE-2 trial of denifanstat in patients with MASH Preparations are ongoing to ...
In NAFLD-related cirrhosis, liver histology may no longer show inflammation or even steatosis, and this likely represents the largest proportion of cases often referred to as "cryptogenic cirrhosis." ...
Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of ...
Four in 10 people are thought to have a potentially serious liver condition known as MASLD. Reversing it is possible if you ...
Researchers have long known that outcomes for alcohol-associated liver disease (ALD) aren't equal among all races and ...
Fatty liver disease is linked to obesity, alcohol abuse, and metabolic conditions including diabetes. If left untreated, it can lead to serious complications such as non-alcoholic steatohepatitis ...
The Union Health Ministry has introduced revised operational guidelines and a training module for Non-Alcoholic Fatty Liver Disease (NAFLD) to enhance patient care. NAFLD is a growing public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback